Upgrade to SI Premium - Free Trial

Incyte acquires Vega Therapeutics for $1.25B upfront

July 6, 2026 8:39 AM
Incyte (Nasdaq: INCY) has completed its acquisition of Vega Therapeutics, Inc., a wholly owned subsidiary of Star Therapeutics LLC, for ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Mergers and Acquisitions